These results demonstrate that HIF-1α plays a vital role in metastatic tumor outgrowth and TAM plasticity in the bone driven by ASH1L, suggesting the potential of HIF-1α targeted therapy in PCa patients with metastasis. This evidence concerns the gene HIF1A and neoplasm.